Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / CL A
-
Number of holders
-
215
-
Total 13F shares, excl. options
-
22,328,924
-
Shares change
-
+3,794,586
-
Total reported value, excl. options
-
$4,565,328,716
-
Value change
-
+$828,204,827
-
Put/Call ratio
-
23.7%
-
Number of buys
-
142
-
Number of sells
-
-59
-
Price
-
$204.43
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2019
253 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q4 2019.
REATA PHARMACEUTICALS INC - CL A (RETA) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,328,924 shares
.
Largest 10 shareholders include CPMG Inc (3,063,567 shares), WELLINGTON MANAGEMENT GROUP LLP (2,392,674 shares), BlackRock Inc. (2,243,871 shares), VANGUARD GROUP INC (2,166,886 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,373,184 shares), FRANKLIN RESOURCES INC (1,243,131 shares), Cormorant Asset Management, LP (816,400 shares), STATE STREET CORP (510,771 shares), Duquesne Family Office LLC (426,719 shares), and FMR LLC (358,968 shares).
This table shows the top 215 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.